USP22 drives colorectal cancer invasion and metastasis via epithelial-mesenchymal transition by activating AP4

Yongmin Li; Yanmei Yang; Jingwen Li; He Liu; Fuxun Chen; Bingyang Li; Binbin Cui; Yanlong Liu

doi:10.18632/oncotarget.15950

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

USP22 drives colorectal cancer invasion and metastasis via epithelial-mesenchymal transition by activating AP4

Yongmin Li, Yanmei Yang, Jingwen Li, He Liu, Fuxun Chen, Bingyang Li, Binbin Cui and Yanlong Liu _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:32683-32695. https://doi.org/10.18632/oncotarget.15950

Metrics: PDF 1947 views | HTML 2867 views | ?

Abstract

Yongmin Li1,*, Yanmei Yang2,*, Jingwen Li1,*, He Liu1, Fuxun Chen2, Bingyang Li2, Binbin Cui1, Yanlong Liu1

1Department of Colorectal Surgery, The Affiliated Tumor Hospital of Harbin Medical University, Harbin 150081, China

2Center for Endemic Disease Control, Chinese Center for Disease Control and Prevention, Harbin Medical University, Harbin 150081, China

*These authors contributed equally to this work

Correspondence to:

Binbin cui, email: [email protected]

Yanlong Liu, email: [email protected]

Keywords: USP22, liver metastasis, colorectal cancer, EMT, AP4

Received: October 12, 2016 Accepted: February 22, 2017 Published: March 06, 2017

ABSTRACT

Ubiquitin specific peptidase 22 (USP22), a putative cancer stem cell marker, is overexpressed in liver metastases of colorectal cancer (CRC). However, the mechanism by which USP22 promotes CRC metastasis remains largely unknown. Here, we report that USP22 and AP4 are simultaneously overexpressed during TGF-β1-induced CRC cell epithelial-mesenchymal transition (EMT). USP22 up-regulation enhances CRC cell migration and invasion and EMT-related marker and AP4 expression, but these effects are partly blocked by AP4 knockdown. In addition, USP22 binds to the promoter region of AP4 to activate its transcription. In vivo, elevated USP22 expression promotes CRC cell metastasis to the lungs in nude mice, as evidenced by the fact that CRC metastatic nodules stain deeply positive for USP22 and AP4. In human CRC tissues, the genes encoding USP22 and AP4 are overexpressed in metastatic liver lesions compared with primary cancer tissues, and their overexpression is significantly associated with poor CRC patient survival. These findings indicate that USP22 and AP4 may serve as prognostic markers for predicting the risk of developing distant metastases in CRC.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 15950

Publication Alerts

Research Papers:

USP22 drives colorectal cancer invasion and metastasis via epithelial-mesenchymal transition by activating AP4

Abstract